Rana S K, Bray J, Menzies-Gow N, Jameson J, Payne James J J, Frost P, Silk D B
Department of Gastroenterology and Nutrition, Central Middlesex Hospital Trust, Acton Lane, London, NW10 7NS, UK.
Clin Nutr. 1992 Dec;11(6):337-44. doi: 10.1016/0261-5614(92)90084-4.
The present study was undertaken to investigate the short term clinical efficacy of oral dietary supplements administered post-operatively to patients undergoing predetermined moderate to severe gastrointestinal surgery. Trial end points for comparison included effects of oral dietary supplements on nutritional intake, nutritional status and incidence of serious complications. 54 patients who were scheduled to undergo predetermined moderate to major gastrointestinal surgical procedures entered the study. They were randomly assigned to receive a normal ward diet post-operatively or the same diet supplemented ad libitum by an oral nutritional sip feed. The study period was defined as commencing from the day patients were adjudged to be capable of ingesting 'free fluids' to the day of hospital discharge. 40 patients (20 in each group) completed the study. The mean daily energy intake (KCal/day) assessed from 7 day food diaries was significantly higher in the treatment group (1833 +/- SEM 99) than in the control group (1108 +/- 56, p < 0.0001). This increase occurred not only as a consequence of energy intake from the oral dietary supplements (470 +/- 30) but also because more energy was consumed from the ward diet by the treatment than the control patients (1353 +/- 92 vs 1108 +/- 56, p < 0.02). The mean daily protein intake g/day in the treatment group (66.0 +/- 3.4) was also greater than in the control group (52.9 +/- 29 p < 0.0001). This difference was due solely to the intake in protein from the oral dietary supplements (15.7 +/- 1.0), protein intake from the ward diet being similar in the treatment (50.1 +/- 3.2) and control (52.9 +/- 29) groups. Patients in the treatment group maintained their pre-operative weight where as control patients had lostsignificant amount of their pre-operative weight by study day 3 (4.5 +/- 12 kg and by discharge (4.7 +/- 1.2 kg, p < 0.02). Pre-operative muscle function as evidenced by grip strength dynamometry decreased to a greater extent in the control than treatment group patients by study day 3 (14.6 +/- 2.2 KPa vs 2.8 +/- 2.4 < 0.03) and by discharge (10.4 +/- 3.1 KPa vs 0.10 +/- 1.9 p < 0.03). The incidence of serious infections (pneumonia, wound infection) was significantly higher in the control group (10) than in the treatment group (3, p < 0.02). It is concluded that the prescription of oral dietary supplements on an ad libitum basis to post-operative patients undergoing moderate to major gastrointestinal surgery results in clinically significant short term benefits.
本研究旨在调查对预定进行中度至重度胃肠道手术的患者术后给予口服膳食补充剂的短期临床疗效。用于比较的试验终点包括口服膳食补充剂对营养摄入、营养状况和严重并发症发生率的影响。54例计划进行预定的中度至大型胃肠道手术的患者进入了该研究。他们被随机分配为术后接受普通病房饮食或同样的饮食并随意补充口服营养流食。研究期定义为从患者被判定能够摄入“自由流质”之日起至出院日。40例患者(每组20例)完成了研究。根据7天食物日记评估,治疗组的平均每日能量摄入量(千卡/天)(1833±标准误99)显著高于对照组(1108±56,p<0.0001)。这种增加不仅是由于口服膳食补充剂的能量摄入(470±30),还因为治疗组患者从病房饮食中消耗的能量比对照组更多(1353±92对1108±56,p<0.02)。治疗组的平均每日蛋白质摄入量(克/天)(66.0±3.4)也高于对照组(52.9±2.9,p<0.0001)。这种差异完全是由于口服膳食补充剂中的蛋白质摄入量(15.7±1.0),治疗组(50.1±3.2)和对照组(52.9±2.9)从病房饮食中的蛋白质摄入量相似。治疗组患者维持了术前体重,而对照组患者在研究第3天(4.5±1.2千克)和出院时(4.7±1.2千克)术前体重显著下降(p<0.02)。到研究第3天(14.6±2.2千帕对2.8±2.4,<0.03)和出院时(10.4±3.1千帕对0.10±1.9,p<0.03),通过握力测力计证明,对照组患者术前肌肉功能下降程度大于治疗组患者。对照组严重感染(肺炎、伤口感染)的发生率(10例)显著高于治疗组(3例,p<0.02)。得出的结论是,对进行中度至大型胃肠道手术的术后患者随意开具口服膳食补充剂可带来临床上显著的短期益处。